Iniciar sesión

Andreas Giannakou

Oncology R&D group

Pfizer Worldwide Research and Development

BIOGRAPHY

Andreas Giannakou has not added Biography.

If you are Andreas Giannakou and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.

Oncotarget Feb, 2015 | Pubmed ID: 25671303

Purine Nucleotide Availability Regulates mTORC1 Activity through the Rheb GTPase.

Cell reports 06, 2017 | Pubmed ID: 28658616

Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.

Proceedings of the National Academy of Sciences of the United States of America 12, 2018 | Pubmed ID: 30487219

INSTITUTIONS

Pfizer Worldwide Research and Development

JOVE ARTICLES

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Shuang Chen¹,

Andreas Giannakou¹,

Jonathon Golas¹,

Kenneth G. Geles¹

¹Oncology R&D group, Pfizer Worldwide Research and Development

Cancer Research

Privacidad

Condiciones de uso

Políticas

Contáctenos

RECOMIENDE A LA BIBLIOTECA

BOLETINES de JoVE

Investigación

JoVE Journal
Colecciones de métodos
JoVE Encyclopedia of Experiments
Archivo

Educación

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centro de recursos académicos
Faculty Site

Autores

Descripción
Proceso de publicación
Comité editorial
Ámbito y políticas
Revisión por pares
Preguntas frecuentes
Enviar

Bibliotecarios

Descripción
Testimonios
Suscripciones
Acceso
Recursos
Junta Asesora de Bibliotecarios
Preguntas frecuentes

ACERCA DE JoVE

Descripción
Liderazgo
Blog

Andreas Giannakou

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Oncology R&D group

Pfizer Worldwide Research and Development

Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression

Oncology R&D group